Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
60 Cards in this Set
- Front
- Back
|
Cyclophosphamide (Cytoxan) Indications
|
Hodgkin Lymphoma, Non-Hodkin lymphoma, Multiple Myeloma, Solid Tumors
|
|
|
Cyclophosphamide (Cytoxan) Contraindications
|
Urinary Obstruction
|
|
|
Cyclophosphamide (Cytoxan) Dosages/Availability
|
25mg, 50mg; IV
|
|
|
Altrtamine (Hexalen) Indications
|
Ovarian CA
|
|
|
Altrtamine (Hexalen) Contraindications
|
Bone marrow Depression
|
|
|
Altrtamine (Hexalen) Dosages/Availability
|
50mg
|
|
|
Methotrexate (MTX) Indications
|
Breat CA, Epidermoid head&neck CA, meningeal leukemia, osteosarcoma, trophoblastic tumors.
|
|
|
Methotrexate (MTX) Contraindications
|
pregnancy, breast-feeding, immunodeficiency syndromes, hx of alcohol abuse, hepatic disease/impairment, blood dyscrasia, myelosuppression,
|
|
|
Methotrexate (MTX) Dosages/Availability
|
2.5mg; IM; IV; IT
|
|
|
Hydroxyurea (Hydrea) Indications
|
Solid Tumors, squamous cell head/neck CA
|
|
|
Hydroxyurea (Hydrea) Contraindications
|
myelosuppression, pregnancy, severe anemia,
|
|
|
Hydroxyurea (Hydrea) Dosages/Availability
|
500mg
|
|
|
Doxorubicin (Adriamycin) Indications
|
ALL, AML, solid tumors
|
|
|
Doxorubicin (Adriamycin) Contraindications
|
IM or SC administration, prior anthracycline tx at max cumulative dose, recent MI, severe arrhythmia's, impaired cardiac function, severe hepatic impairment.
|
|
|
Doxorubicin (Adriamycin) Dosages/availability
|
IV; 40-75mg/m2
|
|
|
Vincristine (Oncovin) Indications
|
ALL, Hodgkin lymphoma, non-Hodgkin lymphoma, solid tumors.
|
|
|
Vincristine (Oncovin) Contraindications
|
intracathecal (IT) admin
|
|
|
Vincristine (Oncovin) dosages/ availability
|
1.4mg/m2
|
|
|
Docetaxel (Taxotere) indications
|
Breast CA, non-small lung cell CA, metastatic castration-resistant prostate CA, advanced gastric CA, squamous cell head/neck CA
|
|
|
Docetaxel (Taxotere) contraindications
|
ANC<1500, hypersensitivity to polysorbate 80, Plt<100,000, elevated bilirubin, avoid pregnancy and breast-feeding.
|
|
|
Docetaxel (Taxotere) dosages/availability
|
60-100mg/m2; IV
|
|
|
Bexarotene (Targretin) indications
|
cutaneous T-cell lymphoma
|
|
|
Bexarotene (Targretin) contraindication
|
pregnancy, vitamin A> 15,000 units/day
|
|
|
Bexarotene (Targretin) dosages/availability
|
300mg/m2; PO
|
|
|
Interferon-alpha-2b, recombinant (Intron-A) indications
|
external condyloma acuminate, hairy cell leukemia, chronic hepatitis B/C infection, Kaposi sarcoma, melanoma, non-Hodgkin lymphoma
|
|
|
Interferon-alpha-2b, recombinant (Intron-A) contraindications
|
autoimmune hepatitis, hepatic impairment, severe depression, hx of severe psychiatric disorder, HBV, HCV, Kaposi sarcoma
|
|
|
Interferon-alpha-2b, recombinant (Intron-A) dosages/availability
|
1-30 million units; SC; IM; Intra-lesional
|
|
|
Gardasil 1 indications
|
Immunization
|
|
|
Gardasil 1 contraindications
|
hypersensitivity to yeast
|
|
|
Gardasil 1 dosages/availability
|
0.5ml; IMx3 at 0, 2, and 6 months for 18-26 yo females
|
|
|
Gardasil 2 indications
|
prevention of Anal cancer caused by HPV types 16, 18, and genital warts caused by HPV types 6, 11, 16, 18
|
|
|
Gardasil 2 contraindications
|
hypersensitivity to yeast
|
|
|
Gardasil 2 dosages/availability
|
0.5ml; IMx3 at 0, 2, and 6 months for 18-26 yo females
|
|
|
Dasatinib (Sprycel) indications
|
Ph-Positive CML, Refractory Ph-positive ALL
|
|
|
Dasatinib (Sprycel) contraindications
|
Pulmonary HTN
|
|
|
Dasatinib (Sprycel) Dosages/Availability
|
100-140mg; PO qd
|
|
|
Sorafenib (Nexavar) Indications
|
unresectable hepatocellular CA, renal cell CA, refectory advanced differentiated thyroid CA
|
|
|
Sorafenib (Nexavar) Contraindications
|
major surgery, GI perforation, uncorrected electrolyte abnormalities, congenital long QT prolongation syndrome
|
|
|
Sorafenib (Nexavar) Dosages/Availability
|
400mg; PO bid
|
|
|
Cetuximab (Erbitux) Indications
|
metastatic colorectal CA, Squamous cell head/neck CA
|
|
|
Cetuximab (Erbitux) Contraindications
|
hypersensitivity
|
|
|
Cetuximab (Erbitux) dosages/availability
|
250mg/m2 qwk
|
|
|
Trastuzumab (Herceptin) Indications
|
metastatic breast CA, metastatic gastric CA
|
|
|
Trastuzumab (Herceptin) Contraindications
|
none
|
|
|
Trastuzumab (Herceptin) dosages/availability
|
2-6mg/kg IV
|
|
|
Bevacizumab (Avastin) Indications
|
metastatic colorectal CA, advanced nonsquamous cell CA, progressive glioblastoma
|
|
|
Bevacizumab (Avastin) Contraindications
|
hypersensitivity
|
|
|
Bevacizumab (Avastin) dosages/availability
|
5-15mg/kg IV
|
|
|
Bortezomib (Velcade) Indications
|
multiple myeloma, mantle cell lymphoma
|
|
|
Bortezomib (Velcade) Contraindications
|
hypersensitivity to boron/mannitol, intrathecal (IT) administration
|
|
|
Bortezomib (Velcade) Dosages/Availability
|
1.3mg/m2 SC; IV
|
|
|
Tensirolimus (Torisel) Indications
|
advanced renal cell CA
|
|
|
Tensirolimus (Torisel) Contraindications
|
ANC<1000, Plt<75,000, bilirubin>1.5xULN
|
|
|
Tensirolimus (Torisel) Dosages/Availability
|
25mg IV qwk
|
|
|
Rituximab (Rituxan) Indications
|
relapsed, refactory, non-progressing, or previously untreated non-Hodgkin lymphoma
|
|
|
Rituximab (Rituxan) Contraindications
|
Hypersensitivity to murine proteins
|
|
|
Rituximab (Rituxan) Dosages/Availability
|
250-375mg/m2 IV
|
|
|
Interferon beta-1b (Betaseron) Indications
|
relapsing MS
|
|
|
Interferon beta-1b (Betaseron) Contraindications
|
hypersensitivity to albumin or mannitol
|
|
|
Interferon beta-1b (Betaseron) Dosages/Availability
|
0.25mg SC qod
|
